Golden State Wealth Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.61K Buy
91
+64
+237% +$2.03K ﹤0.01% 1354
2026
Q1
$850 Hold
27
﹤0.01% 1471
2025
Q4
$795 Sell
27
-467
-95% -$13K ﹤0.01% 1545
2025
Q3
$12.5K Buy
494
+27
+6% +$658 ﹤0.01% 1048
2025
Q2
$11.2K Hold
467
﹤0.01% 1053
2025
Q1
$10.7K Hold
467
﹤0.01% 983
2024
Q4
$11.8K Buy
+467
New +$11.8K ﹤0.01% 924

Other funds holding RTO

Golden State Wealth Management's RTO Position: Q2 2026 in Review

Golden State Wealth Management increased its Rentokil (RTO) stake by 237% in Q2 2026, buying an estimated $2.03K and bringing the position to 91 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Golden State Wealth Management first reported a position in RTO in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.5K in Q3 2025. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Golden State Wealth Management held 91 shares of Rentokil worth $2.61K as of Q2 2026.
  • Golden State Wealth Management bought 64 Rentokil shares in Q2 2026, an estimated $2.03K.
  • Rentokil made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1354 holding.
  • Golden State Wealth Management first reported a position in Rentokil in Q4 2024 and has held it in 7 quarters since.
  • Golden State Wealth Management's Rentokil position peaked at $12.5K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.